Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 386715-34-0 | MDL No. : | MFCD02173905 |
Formula : | C7H5F3N2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PDBGSSVKKHIEBN-UHFFFAOYSA-N |
M.W : | 206.19 | Pubchem ID : | 2777886 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 44.7 |
TPSA : | 71.0 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.67 cm/s |
Log Po/w (iLOGP) : | 1.38 |
Log Po/w (XLOGP3) : | 1.25 |
Log Po/w (WLOGP) : | 2.89 |
Log Po/w (MLOGP) : | 1.16 |
Log Po/w (SILICOS-IT) : | 2.98 |
Consensus Log Po/w : | 1.93 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.12 |
Solubility : | 1.58 mg/ml ; 0.00767 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.34 |
Solubility : | 0.944 mg/ml ; 0.00458 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.71 |
Solubility : | 0.402 mg/ml ; 0.00195 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.83 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P322-P330-P332+P313-P337+P313-P340-P362-P363-P403-P403+P233-P405-P501 | UN#: | N/A |
Hazard Statements: | H302-H312-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In ethanol Heating / reflux; | 10.5 g 6-Trifluoromethyl-thionicotinamide (derived from 6-Trifluoromethyl-nicotinic acid according to the method described for 5-Chloromethyl-4-methyl-2-(1-methyl-cyclohexyl)-oxazole and 5-Chloromethyl-2-(4,4-difluoro-cyclohexyl)-4-methoxymethyl-thiazole) and 10.0 g 2-Chloro-4-methoxy-3-oxo-butyric acid methyl ester were dissolved in 100 ml ethanol and heated under reflux overnight. The cooled reaction mixture was evaporated under reduced pressure and the resulting residue was purified by RP-HPLC to obtain 1.9 g 4-Methoxymethyl-2-(6-trifluoromethyl-pyridin-3-yl)-thiazole-5-carboxylic acid methyl ester.C13H11F3N2O3S (332.30), MS (ESI): 333.0 (M+H+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In ethanol at 95℃; for 36h; | 1 Step 1: Ethyl 2-chloroacetate (4.77 mL, 32.7 mmol) was added to a solution of 6- (trifluoromethyl)pyridine-3-carbothioamide (5.0 g, 24.25 mmol) in ethanol (80 mL) and the mixture was heated to reflux at 95°C for 36 h. After cooling to rt, the resulting suspension was filtered off and dried in vacuum give ethyl 4-methyl-2-(6-(trifluoromethyl)pyridin-3-yl)thiazole-5- carboxylate. The filtrate was concentrated and then triturated with a small amount of EtOH, filtered off cold and dried in vacuo to give more ethyl 4-methyl-2-(6-(trifluoromethyl)pyridin-3- yl)thiazole-5-carboxylate. LCMS (method b) m/z317.1 [M+H]+, tR = 1.25 min.1H NMR (400 MHz, DMSO-d6) δ ppm 9.35 (s, 1H), 8.64 (d, J = 7.4 Hz, 1H), 8.06 (d, J = 8.3 Hz, 1H), 4.33 (q, J = 7.2 Hz, 2H), 2.74 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H). | |
In ethanol at 95℃; for 36h; | 1 Step 1: Ethyl 2-chloroacetate (4.77 mL, 32.7 mmol) was added to a solution of 6- (trifluoromethyl)pyridine-3-carbothioamide (5.0 g, 24.25 mmol) in ethanol (80 mL) and the mixture was heated to reflux at 95°C for 36 h. After cooling to rt, the resulting suspension was filtered off and dried in vacuum give ethyl 4-methyl-2-(6-(trifluoromethyl)pyridin-3-yl)thiazole-5- carboxylate. The filtrate was concentrated and then triturated with a small amount of EtOH, filtered off cold and dried in vacuo to give more ethyl 4-methyl-2-(6-(trifluoromethyl)pyridin-3- yl)thiazole-5-carboxylate. LCMS (method b) m/z317.1 [M+H]+, tR = 1.25 min.1H NMR (400 MHz, DMSO-d6) δ ppm 9.35 (s, 1H), 8.64 (d, J = 7.4 Hz, 1H), 8.06 (d, J = 8.3 Hz, 1H), 4.33 (q, J = 7.2 Hz, 2H), 2.74 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H). | |
In ethanol at 95℃; for 36h; | Step 1: Ethyl 2-chloroacetate (4.77 mL, 32.7 mmol) was added to a solution of 6- (trifluoromethyl)pyridine-3-carbothioamide (5.0 g, 24.25 mmol) in ethanol (80 mL) and the mixture was heated to reflux at 95°C for 36 h. After cooling to rt, the resulting suspension was filtered off and dried in vacuum give ethyl 4-methyl-2-(6-(trifluoromethyl)pyridin-3-yl)thiazole-5- carboxylate. The filtrate was concentrated and then triturated with a small amount of EtOH, filtered off cold and dried in vacuo to give more ethyl 4-methyl-2-(6-(trifluoromethyl)pyridin-3- yl)thiazole-5-carboxylate. LCMS (method b) m/z317.1 [M+H]+, tR = 1.25 min.1H NMR (400 MHz, DMSO-d6) δ ppm 9.35 (s, 1H), 8.64 (d, J = 7.4 Hz, 1H), 8.06 (d, J = 8.3 Hz, 1H), 4.33 (q, J = 7.2 Hz, 2H), 2.74 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: ethanol / 36 h / 95 °C 2: lithium hydroxide monohydrate; lithium hydroxide monohydrate / ethanol / 1.5 h / 20 °C |
[ 387350-39-2 ]
3-(Aminomethyl)-6-(trifluoromethyl)pyridine
Similarity: 0.84
[ 1956369-51-9 ]
(6-(Trifluoromethyl)pyridin-3-yl)methanamine hydrochloride
Similarity: 0.82
[ 175277-51-7 ]
5-(Trifluoromethyl)pyridine-2-carbothioamide
Similarity: 0.80
[ 175277-51-7 ]
5-(Trifluoromethyl)pyridine-2-carbothioamide
Similarity: 0.80
[ 387350-39-2 ]
3-(Aminomethyl)-6-(trifluoromethyl)pyridine
Similarity: 0.84
[ 1956369-51-9 ]
(6-(Trifluoromethyl)pyridin-3-yl)methanamine hydrochloride
Similarity: 0.82
[ 175277-51-7 ]
5-(Trifluoromethyl)pyridine-2-carbothioamide
Similarity: 0.80
[ 387350-39-2 ]
3-(Aminomethyl)-6-(trifluoromethyl)pyridine
Similarity: 0.84
[ 1956369-51-9 ]
(6-(Trifluoromethyl)pyridin-3-yl)methanamine hydrochloride
Similarity: 0.82
[ 175277-51-7 ]
5-(Trifluoromethyl)pyridine-2-carbothioamide
Similarity: 0.80
[ 387350-39-2 ]
3-(Aminomethyl)-6-(trifluoromethyl)pyridine
Similarity: 0.84
[ 1956369-51-9 ]
(6-(Trifluoromethyl)pyridin-3-yl)methanamine hydrochloride
Similarity: 0.82
[ 175277-51-7 ]
5-(Trifluoromethyl)pyridine-2-carbothioamide
Similarity: 0.80